Skip to content
Advertisement
When Appliance Fail?

Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'

Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.

schedule 10:00 visibility 42 views
Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'
Source: NPR News
Kalshi and Polymarket say allowing people to bet on the outcomes of clinical trials and FDA drug approvals provides valuable information about drug development. But researchers warn the bets could incentivize insider trading and interfere with the integrity of the process.

Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.

(Image credit: Fred Tanneau)

newspaper

Originally published at

NPR News

open_in_new Read Full Article

Related Articles

Read More

Anthropic is asking Wall Street to believe in AGI
Science

Anthropic is asking Wall Street to believe in AGI

Today on Decoder, I’m joined by Joey Brookhart, an analyst at the chip and AI research firm SemiAnalysis, to help me dig into the story inside the numbers of the Anthropic IPO filing — a document known as an S-1. Anthropic just filed its S-1 to go...

The Verge
Six popular sugar substitutes linked to faster brain aging
Science

Six popular sugar substitutes linked to faster brain aging

A study of nearly 13,000 adults found that people consuming the most artificial sweeteners experienced a 62% faster decline in memory and thinking skills, equivalent to approximately 1.6 additional years of brain aging. Six popular sweeteners were...

Science Daily
Your Appliance Broke?
Reliable Repair for